First Header Logo Second Header Logo

Connection

David Kline to Cardiovascular Agents

Back to Details
This is a "connection" page, showing publications David Kline has written about Cardiovascular Agents.
David Kline
Connection Strength
0.147
Cardiovascular Agents
  1. Arnold WD, Kline D, Sanderson A, Hawash AA, Bartlett A, Novak KR, Rich MM, Kissel JT. Open-label trial of ranolazine for the treatment of myotonia congenita. Neurology. 2017 Aug 15; 89(7):710-713.
    View in: PubMed
    Score: 0.147
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.